Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
Anticancer Res. 2010 May;30(5):1747-9.
The prognosis of prostate cancer (PC) is mainly determined by the presence or absence of metastases. An isolated testicular metastasis of PC is rare.
A 71-year-old patient with PC presented with an increased serum prostate-specific antigen (PSA) level of 2.07 ng/ml two and a half years after radical prostatectomy. Assuming a local recurrence in the prostatic fossa, local radiotherapy with 64.8 Gy was performed. Unfortunately, the PSA level rose again, accompanied by a swelling of the left testis approximately one month after radiotherapy. A unilateral orchiectomy was then performed, presenting a testicular metastasis of the PC. After orchiectomy, the PSA decreased to <0.07 ng/ml. Two years later, the patient is still tumour-free.
Careful clinical follow-up of patients with rising serum PSA level is important to recognize isolated, locally treatable metastastic disease. In particular, rare metastatic sites such as the testis or the epididymis should be taken into account before treatment of biochemical recurrence is initiated.
前列腺癌(PC)的预后主要取决于是否存在转移。PC 的孤立性睾丸转移较为罕见。
一名 71 岁的 PC 患者,在根治性前列腺切除术后两年半,出现血清前列腺特异性抗原(PSA)水平升高至 2.07ng/ml。考虑为前列腺窝局部复发,行 64.8Gy 局部放疗。不幸的是,放疗后 1 个月 PSA 水平再次升高,同时伴有左侧睾丸肿胀。随后行单侧睾丸切除术,提示 PC 的睾丸转移。睾丸切除术后,PSA 降至<0.07ng/ml。两年后,患者仍无肿瘤。
对于 PSA 水平升高的患者,仔细的临床随访对于识别孤立的、局部可治疗的转移性疾病很重要。在开始治疗生化复发之前,应考虑到睾丸或附睾等罕见的转移部位。